Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …
RBM Landewé, FPB Kroon, A Alunno, A Najm… - Annals of the …, 2022 - ard.bmj.com
The first EULAR provisional recommendations on the management of rheumatic and musculoskeletal diseases (RMDs) in the context of severe acute respiratory syndrome …
FPB Kroon, A Najm, A Alunno, JW Schoones… - Annals of the …, 2022 - ard.bmj.com
Objectives Perform a systematic literature review (SLR) on risk and prognosis of SARS-CoV- 2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …
V Furer, C Rondaan, N Agmon-Levin, S Van Assen… - RMD open, 2021 - rmdopen.bmj.com
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …
JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2022 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …
ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2), вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
F Haslak, A Gunalp, MN Cebi, M Yildiz… - … journal of rheumatic …, 2022 - Wiley Online Library
Objective Considering the concerns regarding the coronavirus disease‐2019 (COVID‐19) vaccine safety among pediatric patients with inflammatory rheumatic diseases (IRD) due to a …
JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2023 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …